Search Results 951-960 of 18975 for Neutrophil

  1. Clinical trials - Oncology (Medical)

    MC1733, Phase I Trial of Intratumoral Administration of a Measles Virus Derivative Expressing the Helicobacter pylori Neutrophil-activating Protein (NAP) ...

  2. Ruxolitinib Phosphate and Danazol in Treating Anemia in Patients with Myelofibrosis - Mayo Clinic

    Absolute neutrophil count (ANC) ≥ 1000/uL; Platelet count ≥ 50,000/uL; Serum creatinine ≤ 1.5 x the upper limit of normal (ULN); Total bilirubin ≤ 1.5 x ...

  3. Ipilimumab and Nivolumab as Adjuvant Treatment of Mucosal Melanoma - Mayo Clinic

    ECOG Performance Status (PS) ≤ 1. The following laboratory values obtained ≤ 14 days prior to registration: Hematological. Absolute Neutrophil Count (ANC) ≥ ...

  4. A Trial of RAdium-223 and SABR Versus SABR for oligomEtastatic Prostate caNcerS (RAVENS) - Mayo Clinic

    Participation eligibility · Before the first administration of Xofigo, the absolute neutrophil count (ANC) should be ≥ 1.5 x 10^9/L; · The platelet count ≥ 100 ...

  5. Cisplatin and Gemcitabine Hydrochloride With or Without ATR Kinase Inhibitor VX-970 in Treating Patients With Metastatic Urothelial Cancer - Mayo Clinic

    Absolute neutrophil count ≥ 1,500/mcL; Platelets ≥ 100,000/mcL; Total bilirubin within normal institutional limits; Aspartate aminotransferase (AST) (serum ...

  6. Androgen Deprivation To Enrich PSMA Expression And Improve Sensitivity Of Staging PSMA PET/C - Mayo Clinic

    Absolute neutrophil count (ANC) ≥ 1500/mm3. Platelet count ≥ 100,000/mm3. Male patients who are committed to undertaking the following measures for the ...

  7. Clinical trials - Oncology (Medical)

    MC1733, Phase I Trial of Intratumoral Administration of a Measles Virus Derivative Expressing the Helicobacter pylori Neutrophil-activating Protein (NAP) ...

  8. Veliparib and Topotecan Hydrochloride in Treating Patients with Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer - Mayo Clinic

    Absolute neutrophil count ≥ 1500/mcL; Hemoglobin ≥ 9.0 g/dL; Platelets ≥ 100,000/mcL; Total bilirubin ≤ 1.5x the upper limit of normal (ULN); Serum glutamic ...

  9. Vemurafenib and Cobimetinib in Treating Patients With BRAF V600E Mutation Positive Craniopharyngioma - Mayo Clinic

    Absolute neutrophil count >= 1500/mm^3; Platelets >= 100,000/mm^3; Creatinine =< 1.5 mg/dL OR creatinine clearance >= 45mL/min; Bilirubin =< 1.5 upper limit of ...

  10. A Study to Evaluate Triapine Combined with Lutetium Lu 177 Dotatate for Gastroenteropancreatic Neuroendocrine Tumors - Mayo Clinic

    absolute neutrophil count ≥ 1,500/mcL;; platelets ≥ 75,000/mcL;; total bilirubin ≤ 3 × institutional upper limit of normal (ULN);; AST(SGOT)/ALT(SGPT) ≤ 3 ...